TPG and AmerisourceBergen Acquire OneOncology from General Atlantic
April 20, 2023
TPG has agreed to acquire a majority interest in OneOncology and AmerisourceBergen will take a roughly 35% minority stake for approximately $685 million, valuing OneOncology at $2.1 billion. OneOncology's affiliated practices, physicians, and management will retain minority ownership as the parties form a new joint venture; the network includes over 900 affiliated providers across 14 states and the deal is expected to close by the end of September 2023.
- Buyers
- TPG, AmerisourceBergen, OneOncology affiliated practices, physicians and management team
- Targets
- OneOncology
- Sellers
- General Atlantic
- Industry
- Healthcare Services
- Location
- Tennessee, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
OneOncology Acquires United Urology Group from Audax Private Equity
August 20, 2024
Healthcare Services
OneOncology has agreed to acquire United Urology Group (UUG) from Audax Private Equity, with the deal expected to close by the end of 2024; terms were not disclosed. UUG is a national urology management services organization supporting ~250 physicians and ~1,300+ employees across multiple states, and OneOncology plans to integrate UUG's urology capabilities and ancillary services into its physician-led oncology platform.
-
TPG Growth Makes Minority Investment in AnovoRx
January 12, 2022
Healthcare Services
TPG Growth has made a significant minority investment in AnovoRx Holdings, Inc. (Anovo), a specialty pharmacy and patient-support services provider that partners with biopharmaceutical manufacturers to deliver therapies to patients with rare and complex diseases. Financial terms were not disclosed; TPG said the investment will help Anovo expand its service offering, scale operations, and deepen relationships with manufacturer clients and patients.
-
Evolent Health Acquires IPG from TPG Growth for $375M
June 29, 2022
Healthcare Services
Evolent Health agreed to acquire IPG, a provider of surgical cost management solutions for musculoskeletal conditions, from TPG Growth for $375 million in cash plus up to $87 million of contingent consideration. The IPG platform will be integrated into Evolent’s New Century Health business to expand the company's value-based specialty care capabilities and add new payer and ambulatory surgery center relationships; the deal is expected to be immediately accretive to adjusted EBITDA.
-
TPG Completes Majority Investment in iNova Pharmaceuticals
October 31, 2022
Pharmaceuticals
TPG (through its Asia platform) completed a majority investment in iNova Pharmaceuticals, a multinational consumer health and pharmaceutical company, with existing investor Pacific Equity Partners re-investing as a minority co-investor. The deal will support iNova's regional expansion and growth strategy across Southeast and North Asia, and fund channel expansion, product-in-fill and technology investments.
-
OMS360 Adds Pittsburgh Oral Surgery and Secures Growth Financing from TPG Twin Brook
August 21, 2024
Healthcare Services
OMS360 has partnered with Pittsburgh Oral Surgery, adding the four-location oral and maxillofacial practice to its partner network as it expands into Pennsylvania. The transaction coincides with a growth recapitalization for OMS360—a new revolving credit facility and delayed draw term loan provided by TPG Twin Brook—backed by Shore Capital to support further partnerships, systems investment, and hiring.
-
TPG to Acquire Nextech from Thomas H. Lee Partners
July 19, 2023
Healthcare Services
TPG (through its TPG Capital platform) has signed a definitive agreement to acquire Nextech, a provider of clinical and administrative healthcare technology and EMR software for specialty physician practices, from Thomas H. Lee Partners for $1.4 billion. The deal, expected to close in Q3 2023 subject to regulatory review, will allow TPG to expand its healthcare IT / SaaS portfolio and grow Nextech's platform and capabilities.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.